Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy

Go back to Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
NOVO-NORDISK A/S (NYSE: NVO) Delayed: 47.17 --0 (-0%)
Previous Close $47.17    52 Week High $59.00 
Open $47.17    52 Week Low $32.80 
Day High $47.17    P/E N/A 
Day Low $47.17    EPS $0.00 
Volume 385,630